A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
This study is for children with constipation.
Children who completed 3 months of treatment in the earlier study (NCT02042183):
Inclusion Criteria:
Exclusion Criteria:
Louisville, Kentucky 40202, United States
Philadelphia, Pennsylvania 19134, United States
Tacoma, Washington 98405, United States